Skip to main content
Clinical Trials/NCT06144593
NCT06144593RecruitingNot Applicable

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

Hvidovre University Hospital1 site in 1 country14 target enrollmentStarted: January 3, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Enrollment
14
Locations
1
Primary Endpoint
24-hour average sensor glucose

Study Overview

Brief Summary

The primary aim of this randomized cross-over intervention study is to investigate the effect of four weeks of intermittent carbohydrate restriction (alternating between two days of normal dietary intake and two days of carbohydrate restriction to 70-90 grams) on 24-hour average sensor glucose in individuals with type 2 diabetes compared with a four-week control period with normal dietary intake.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Crossover
Primary Purpose
Other
Masking
None

Eligibility Criteria

Ages
35 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Men or women
  • •35-75 years old
  • •BMI >27 kg/m2
  • •Known type 2 diabetes in stable glucose lowering therapy (for three months) or with HbA1c >48 mmol/mol if no glucose lowering therapy

Exclusion Criteria

  • •Anemia (hemoglobin <8 mmol/L for men and <7 mmol/L for women)
  • •TSH outside reference range
  • •Treatment with insulin, sulfonylurea, or SGLT2-inhibitors
  • •Treatment with systemic corticosteroids
  • •HbA1c >70 mmol/mol
  • •eGFR <60 ml/min/1.73 m2
  • •Contraindications for MR-scan: abdominal height exceed limitations of the MR-scanner, pacemaker or other electronic device implanted, implanted metal devices, severe claustrophobia
  • •Food allergies (including lactose and gluten intolerance)
  • •Vegetarian/vegan diet or following of specific dietary plans
  • •Alcohol consumptions >84/168 g/week (women/men)
  • •Strenuous activity level > 120 minutes per week
  • •Weight loss (>5 kg) within the last three months or previous bariatric surgery
  • •High risk of fibrosis of the liver (estimated by FIB4 score > 3.25)

Arms & Interventions

Intermittent carbohydrate restriction

Experimental

Four weeks of intermittent carbohydrate restriction: a dietary regime alternating between two days of restricting carbohydrate intake to 70-90 grams, while energy intake is ad libitum, from fat- and protein-containing foods, and two days of non-restricted diet.

Intervention: Dietary macronutrient composition (Other)

Control arm

No Intervention

Four weeks of free-living with no dietary restrictions.

Outcomes

Primary Outcomes

24-hour average sensor glucose

Time Frame: 24-hour average sensor glucose is measured as the average of eight consecutive days (starting from two days post sensor mounting) from the intermittent carbohydrate restriction period and the corresponding days of the control period (i.e. days 17-24).

A patient-blinded continuous glucose monitoring (CGM) is worn during the last two weeks of both the intervention and control period.

Secondary Outcomes

  • Liver triacylglycerol content(day 30 adjusted for baseline)
  • Fasting plasma concentrations of triacylglycerols(day 30 adjusted for baseline)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Kirstine Nyvold Bojsen-Moeller

MD, PhD, Associate Professor

Hvidovre University Hospital

Study Sites (1)

Loading locations...

Similar Trials

The Metabolic Impact of Intermittent... | Clinical Trial